HomeScienceFDA fast-tracks review of overdose drug naloxone for use without prescription

FDA fast-tracks review of overdose drug naloxone for use without prescription

December 27, 2022

A pharmaceutical nonprofit was granted precedence evaluate from the Meals and Drug Administration to make an affordable overdose-reversal drug to be used with out a prescription.

Source link

Tags
FDA
Naloxone

Drug prices reach new high—in the millions

Entergy (NYSE:ETR) Issues FY22 Earnings Guidance

admin@tradetoday.in https://tradetoday.in

Most Popular

FDA fast-tracks review of overdose drug naloxone for use without prescription

Merck covid drug linked to new virus mutations, study says

Loneliness, social isolation raise risk of heart failure: Study

Ice-cream, bread, breakfast cereal among foods that increases cancer risk

LEAVE A REPLY Cancel reply

Most Popular

Mahindra Lifespaces Q3 net up 33% to Rs 33.21 cr, income rises to Rs 198 cr

Dabur net falls 5.4% to Rs 476 cr in Q3, revenue crosses Rs 3,000 cr mark

Man Infraconstruction Q3 consolidated profit rises 126% to Rs 90.60 crore

HDFC Q3 net profit rises 13% to Rs 3,691 crore, impairments decline

Recent Comments

EDITOR PICKS

Mahindra Lifespaces Q3 net up 33% to Rs 33.21 cr, income rises to Rs 198 cr

Dabur net falls 5.4% to Rs 476 cr in Q3, revenue crosses Rs 3,000 cr mark

Man Infraconstruction Q3 consolidated profit rises 126% to Rs 90.60 crore

POPULAR POSTS

Mahindra Lifespaces Q3 net up 33% to Rs 33.21 cr, income rises to Rs 198 cr

Dabur net falls 5.4% to Rs 476 cr in Q3, revenue crosses Rs 3,000 cr mark

Man Infraconstruction Q3 consolidated profit rises 126% to Rs 90.60 crore

POPULAR CATEGORY

ABOUT US

FOLLOW US